U.S. flag

An official website of the United States government

NM_025215.6(PUS1):c.581_585del (p.Asn194fs) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 21, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003569994.2

Allele description [Variation Report for NM_025215.6(PUS1):c.581_585del (p.Asn194fs)]

NM_025215.6(PUS1):c.581_585del (p.Asn194fs)

Gene:
PUS1:pseudouridine synthase 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
12q24.33
Genomic location:
Preferred name:
NM_025215.6(PUS1):c.581_585del (p.Asn194fs)
HGVS:
  • NC_000012.12:g.131941328_131941332del
  • NG_013039.1:g.17129_17133del
  • NG_013039.2:g.17054_17058del
  • NM_001002019.3:c.497_501del
  • NM_001002020.3:c.497_501del
  • NM_025215.6:c.581_585delMANE SELECT
  • NP_001002019.1:p.Asn166fs
  • NP_001002020.1:p.Asn166fs
  • NP_079491.2:p.Asn194fs
  • NC_000012.11:g.132425870_132425874del
  • NC_000012.11:g.132425873_132425877del
Protein change:
N166fs
Molecular consequence:
  • NM_001002019.3:c.497_501del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001002020.3:c.497_501del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_025215.6:c.581_585del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004325446Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 21, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA).

Fernandez-Vizarra E, Berardinelli A, Valente L, Tiranti V, Zeviani M.

J Med Genet. 2007 Mar;44(3):173-80. Epub 2006 Oct 20.

PubMed [citation]
PMID:
17056637
PMCID:
PMC2598032

Systematic molecular genetic analysis of congenital sideroblastic anemia: evidence for genetic heterogeneity and identification of novel mutations.

Bergmann AK, Campagna DR, McLoughlin EM, Agarwal S, Fleming MD, Bottomley SS, Neufeld EJ.

Pediatr Blood Cancer. 2010 Feb;54(2):273-8. doi: 10.1002/pbc.22244.

PubMed [citation]
PMID:
19731322
PMCID:
PMC2843911
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004325446.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This variant has not been reported in the literature in individuals affected with PUS1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asn194Metfs*2) in the PUS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PUS1 are known to be pathogenic (PMID: 17056637, 19731322, 25058219, 26556812). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024